The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Sipuleucel-T product characterization across different disease states of prostate cancer.
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Eric Jay Small
Honoraria - Dendreon
Other Remuneration - Dendreon
David I. Quinn
Consultant or Advisory Role - Bayer; Dendreon; Genentech; Novartis; Pfizer
Celestia S. Higano
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Dendreon
Daniel W. Lin
Honoraria - Dendreon
Johnna D. Wesley
Employment or Leadership Position - Dendreon
Heather Haynes
Employment or Leadership Position - Dendreon
Frances P. Stewart
Employment or Leadership Position - Sr. Research Assoc
Christian Heinrich Poehlein
Employment or Leadership Position - Principal Biostatistician
James B. Trager
Employment or Leadership Position - Dendreon